Professional Documents
Culture Documents
Clin Pharm Unit 1
Clin Pharm Unit 1
Clinical Pharmacy – arouse out of dissatisfaction with old Clinical Pharmacy Settings
practice norms and the pressing need for a health professional - Hospitals
with a comprehensive knowledge of the therapeutic use of - Community pharmacists
drugs - Nursing homes
- The clinical pharmacy movement began at the - Home-based care services
University of Michigan in the early 1960s - Clinics
- Any other setting where medicines are prescribed and Ex: Diabetes Mellitus – chronic hyperglycemia (high glucose sa
used blood)
- Caused by absolute lack of insulin (Type I – common
Goals of Clinical Pharmacy in children) or relative lack of insulin (Type II DM)
To promote the correct and appropriate use of - Death due to complication
medicinal products and devices. These activities aim at: 1. Assessment
- Minimizing the risk of treatment-induced adverse - Complications is due to blood sugar is poorly
events continued:
*Ex. Steroids o Macrovascular – CAD – risk factor;
- Cushing’s syndrome – buffalo hump Atheroma(plaque) deposit to form
- Continuous use – type C ADR Atherosclerosis, stroke
- Occurs due to long period of administration o Microvascular – Diabetic retinopathy –
- Reversible damage is irreversible
- Addison’s Disease (Adrenal insufficiency) Diabetic nephropathy – in DM –
- No productivity of steroids in the body concentrated blood can lower down
- Due to abrupt withdrawal after 10-14 days of renal blood supply that triggers
administration renin release that activates RAAS
- Fatal then the Aldosterone is used for
- Solution: taper the dose slowly sodium and water retention and it
*Ex. NSAIDS – COX1 – produce prostaglandin as can lead to increase of blood
gastroprotectant volume and blood pressure
- GI irritation KIDNEYS REQUIRE ADEQUATE
o Soln: take it with meals – after 30 mins BLOOD SUPPLY TO FUNCTION
o Add proton pump inhibitor NORMALLY
o Shift to Selective COX2 inhibitors o Diabetic Neuropathy
Increase the risk of thromboembolic 2. Plan
effects - Type I DM – insulin
It is okay to use this as long as - Type II DM – Oral anti-diabetic drugs
there is no history of *Recommend lifestyle modification
thromboembolic effects 3. Monitoring
- Maximizing the clinical effects of medicines - FBS: <126 mg/dL
- Minimizing the expenditures for pharmacological - Pre-prandial RBS: 80-110 mg/dL
treatments - Post-prandial RBS: <140 mg/dL
*Ex. Antiphychotics - HBA1C - <6.5%
- Typical – EPS + cholinergic agents - BP goal: JNC 8 <140/90
- Atypical – less EPS - LDL goal: <100mg/dL
- Eye examination
Three basic components of the clinical role in the practice of 4. Provide drug information/Counselling
pharmacy - Insulin – Arms, thigh
- Communication o Subcutaneous
- Counselling o Rotate the injection site (to prevent
- Consulting lipodystrophy)
o Proper timing of administration
Primary jobs of Clinical Pharmacist Ultrarapid/Insulin LAG – 5
- To interact with the health care team mins before meal or after a
- To interview and assess patient meal
- To make specific therapeutic recommendation Long acting – once a day
- To monitor patient response to drug therapy
- To provide drug information
Intermediate/Protamine – A – No error capacity to
BID – prebreakfast (2/3), cause harm – SALAD
predinner (1/3) B – Error occur, but did not
Regular insulin – 30 min reach the patient
before meals C – Error reached patient,
but no harm
*ADR: hypoglycaemia – prevent by proper timing D – Error occurred that
- Mgt: give glucose supplements resulted in… increase
- Awake: glucose tabs patient monitoring, no
- Unconscious: IV infusion of D50 water patient harm
- First manifestation is tachycardia E – … need for treatment
- Fatal or intervention, temporary
patient harm
Activities of Clinical Pharmacists F – … initial or prolonged
1. Therapeutic Drug Monitoring hospitalization, temporary
- Assuring steady state concentration in patient harm
therapeutic range by blood concentration G – … permanent patient
measurement of drugs with narrow harm
therapeutic indices H – … near death event
*Goal: Ensure that the drug in the body is within
I – … Death
the therapeutic range
- Ex. Allergic Reaction
*Narrow therapeutic indices drugs:
PREVENTION – right drug, dose,
o Digoxin
route, frequency, duration
o Warfarin
Promote rational drug
o Theophylline
therapy
o Phenobarbital
DETECTION – investigating
o Quinidine
unusual circumstances, Rxs
o Phenytoin
MITIGATION – providing ready
o Heparin
access to antidotes
o Amiodarone
Make the condition less
o Aminoglycosides
severe
*Therapeutic Index = Toxic Dose 50/Effective
Ex. Anaphylactic shock –
Dose 50
Epinephrine or IV
*High TI = safer drugs
diphenydramine
2. Drug information
5. Resuscitation or Code Blue
- Information about medications to physicians,
- Prepare medications that may be needed
nurses, other health care practitioners
during a code
3. Patient Care Rounds
- Assist with dose calculation to ensure
- Pharmacists are an integral part of the
therapeutic dose
rounding ream and evaluate drug therapy
First drug given: Epinephrine 1mg ever 3-5 mins
and dosing during rounds
until stable
4. Adverse Drug Events – any adverse events
o Normalize circulation of patient
associated with the use of drugs in human
o Worsen Myocardial Infarction, contract
- Prevention, detection, mitigation of adverse
heart muscle, increase heart rate –
drug events
increase demand of the drug
- Ex. Adverse Drug Reaction – noxious ,
Ventricular tachycardia – do the defribrillation
unintended reaction reaction to a drug
3 times after every defrib. No response – give
- Ex. Medication Error - preventable
Amiodarone or Lidocaine or other arrhythmic
Category in Medication Error
agents
6. Medication Dosing *BSA = √ht (in)x wt(lb) = PI
Dosing adjustment: 3131
- Organ dysfunction – elimination organ
*BSA = √ht (cm)x wt(kg) = KC
kidney for metabolism, liver for elimination
3600
- Age or weight – based on BSA
*Dose = BSA x Adult dose
- Switching between different routed of
1.73 m 2
administration
o A 52-year old patient is weighing 132 lbs
Creatinine is a chemical waste product in the
with a height 5’2’’. The physcian
blood that passes through the kidneys to be
prescribed a medication digoxin with a
filtered and eliminated in urine
dose of 0.25mg. Compute for the dose
CrCl helps to estimate the glomerular filtration
of the patient based on BSA. – 0.23 mg
rate (Gfr): the rate of blood flow through the
7. Formulary – list of drugs available in the specific
kidney
institution
*Creatinine – important biomarker that assess by
8. Anticoagulation – heparin, warfarin
the kidney
- There should be protocols and processes for
- Produce as a product of metabolism of
handling high risk drugs
muscle
- Daily monitoring of laboratory values and
- Normally creatinine is renally excreted
dose adjustment as appropriate
- Increased creatinine = problem in the
*Have narrow therapeutic index
kidney
*Warfarin
*If drug is excreted via kidney, but have kidney
- PT-INR (2 – 3)
disease, the dose should be LOW
- With Prosthetic heart valve (2.5 – 3.5)
*CrCl – close approximate on how your kidneys
- PT-INR > goal with no bleeding
work.
o < 5 temporary stop the dose or
*Cockcroft-Gault formula
reduce the dose
o CrCl = (140-age) x kg x 0.85
o 5 -9 temporary stop the dose
72 x SCr
o > 9 minor bleeding, stop the dose
- 0.85 for female only.
and give Vitamin K
o CrCl = UV
Vit K – antidote for
P
warfarin
U – creatinine in urine
o Moderate to severe bleeding – stop
V – volume of urine for 24 hrs
the dose, give Vit K and give FFP
P – creatinine in plasma
(Fresh Frozen Plasma)
o The serum creatinine of a 72 years-old
*Increase Anticoagulant – Increase bleeding
female weighing 65kg was found to be
9. Nutrition
5mg/dL. What is the CrCl of the patient?
- Sterile preparation of TPN
– 10.44 mL/min
- Resolving incompatibilities and adjusting the
o The plasma creatinine of a patient was
nutritional formula as appropriate
found to be 0.9 mg/dL. Over 24 hour
10. Anti-Infective Stewardship
period, 1250 mL of urine was collected
- Review antibiotic, antiviral, antifungal
and the concentration of creatinine in
medication use by comparing to patient’s
urine was found to be 185mg/dL. What
condition, site of infection, culture and
is the CrCl of the patient? – 178.43
sensitivity results
mL/min
11. Outcomes Management
*Serum Creatinine – amount of serum found
- Participating in compliance with care
in the blood
measures by assuring core therapies are
*High CrCl – Low SCr
received by eligible patients
*Low CrCl and High SCr – have kidney
12. Managing Transition of Care
disfunction
- Medication reconciliation
13. Narcotic Stewardship SOAP Notes
- Pain management using opioid analgesics Subjective
*Ex. Mefanamic acid – NMT 7 days due to GI - Information that explains the reason for the encounter
Irritation and Cardio Problems - Information that the patient reports concerning
*Ketorolac – NMT 5 days due to GI irritation and symptoms, previous treatments, medication used, and
Cardio problems adverse effects encountered
*Tramadol – 5 days habit forming - These are considered nonreproducible date because
14. Pharmacogenomics the information is based on the patient’s interpretation
- Relationship between genomes and the and recall of past events
efficacy elimination, and toxicities of - Identification and Chief complaint
medications - Medical history
- Evaluate genetic code of patients in order to - Review of Systems(ROS)/ Physical Examination
better predict a drug response - Social History
15. Medication Therapy Management Services Objective
- Services that optimize therapeutic outcomes - Information from physical examination laboratory
for individual patients results, diagnostic tests, and present medications
- A systematic process of collecting patient- - Objective data are measurable and reproducible
specific information, assessing medication Assessment
therapies to identify medication-related - A brief but complete description of the problem,
problems, developing a list of medication- including a conclusion or diagnosis that is supported
related problems, and creating plan to logically by the subjective and objective data
resolve them - The assessment should not include a
16. Documentation problem/diagnosis that is not defined above.
- Means by which healthcare professionals Plan
communication with one another - Specific solution for each problem outlined in the
- Physician consultations of the pharmacist assessment
- Drug information question results - Numbered list to match the Assessment
- Relevant drug serum concentrations and - Recommendations for drug dose, frequency, duration
their interpretation - Monitoring
- Patient education - Follow-up